Terms: = Colorectal cancer AND PALB2, ENSG00000083093, 79728
46 results:
1. The Clinical and Genetic Landscape of Hereditary cancer: Experience from a Single Clinical Diagnostic Laboratory.
Tsoulos N; Agiannitopoulos K; Potska K; Katseli A; Ntogka C; Pepe G; Bouzarelou D; Papathanasiou A; Grigoriadis D; Tsaousis GN; Gogas H; Troupis T; Papazisis K; Natsiopoulos I; Venizelos V; Amarantidis K; Giassas S; Papadimitriou C; Fountzilas E; Stathoulopoulou M; Koumarianou A; Xepapadakis G; Blidaru A; Zob D; Voinea O; Özdoğan M; Ergören MÇ; Hegmane A; Papadopoulou E; Nasioulas G; Markopoulos C
Cancer Genomics Proteomics; 2024; 21(5):448-463. PubMed ID: 39191493
[TBL] [Abstract] [Full Text] [Related]
2. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract] [Full Text] [Related]
3. Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and palb2 germline mutations.
Infante M; Arranz-Ledo M; Lastra E; Olaverri A; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
Clin Chim Acta; 2024 Jan; 552():117695. PubMed ID: 38061684
[TBL] [Abstract] [Full Text] [Related]
4. Report on the Effect of the Implementation of an Early Detection and Prevention of cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland.
Kałużewski T; Kubiak I; Bednarek M; Sałamunia J; Kucharska D; Kępczyński Ł; Stempień M; Kubicki T; Trzciński R; Gordon-Sönmez Z; Bartosińska-Dyc A; Gach A; Kałużewski B
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685988
[TBL] [Abstract] [Full Text] [Related]
5. Screening Practices for Breast and Nonbreast cancers in High-Risk Mutation Carriers.
Coogan AC; Lunt LG; Keshwani SS; Sandhu O; Zhang Y; O'Donoghue C; Madrigrano A
J Surg Res; 2023 Nov; 291():388-395. PubMed ID: 37516046
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract] [Full Text] [Related]
7. Personalized Systemic Therapies in Hereditary cancer Syndromes.
Mastrodomenico L; Piombino C; Riccò B; Barbieri E; Venturelli M; Piacentini F; Dominici M; Cortesi L; Toss A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980956
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
Lehman B; Matthäi E; Gercke N; Denzer UW; Figiel J; Hess T; Slater EP; Bartsch DK
Fam Cancer; 2023 Jul; 22(3):323-330. PubMed ID: 36717525
[TBL] [Abstract] [Full Text] [Related]
9. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
[TBL] [Abstract] [Full Text] [Related]
10. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic colorectal cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
[TBL] [Abstract] [Full Text] [Related]
11. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and palb2 in a Tumor-Only Genomic Testing Program.
Bychkovsky BL; Li T; Sotelo J; Tayob N; Mercado J; Gomy I; Chittenden A; Kane S; Stokes S; Hughes ME; Kim JS; Umeton R; Awad MM; Konstantinopoulos PA; Yurgelun MB; Wolpin BM; Taplin ME; Newmark RE; Johnson BE; Lindeman NI; MacConaill LE; Garber JE; Lin NU
Clin Cancer Res; 2022 Jun; 28(11):2349-2360. PubMed ID: 35363308
[TBL] [Abstract] [Full Text] [Related]
12. Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI cancers.
Tan E; Whiting J; Knepper T; Xie H; Imanirad I; Carballido E; Felder S; Frakes J; Mo Q; Permuth JB; Somerer K; Kim R; Anaya DA; Fleming JB; Walko C; Sahin IH
Am J Clin Oncol; 2022 Apr; 45(4):137-141. PubMed ID: 35320814
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
14. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
15. The Effect of Gene Mutations on Metastasis and Overall Survival in Metastatic and Nonmetastatic Colon cancers.
Ozdemir Y; Cag M; Colak E; Coskun N; Basgoz N; Sarici H; Kaan D; Dogan M; Deniz K; Inanc M; Ozkul Y
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3839-3846. PubMed ID: 34967562
[TBL] [Abstract] [Full Text] [Related]
16. 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.
Woodward ER; Green K; Burghel GJ; Bulman M; Clancy T; Lalloo F; Schlecht H; Wallace AJ; Evans DG
Eur J Hum Genet; 2022 Apr; 30(4):413-419. PubMed ID: 34866136
[TBL] [Abstract] [Full Text] [Related]
17. Germline mutations in a DNA repair pathway are associated with familial colorectal cancer.
Xu P; Sun D; Gao Y; Jiang Y; Zhong M; Zhao G; Chen J; Wang Z; Liu Q; Hong J; Chen H; Chen YX; Fang JY
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549727
[TBL] [Abstract] [Full Text] [Related]
18. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and palb2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
19. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M
Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661
[TBL] [Abstract] [Full Text] [Related]
20. Disease spectrum of gastric cancer susceptibility genes.
McKinley SK; Singh P; Yin K; Wang J; Zhou J; Bao Y; Wu M; Pathak K; Mullen JT; Braun D; Hughes KS
Med Oncol; 2021 Mar; 38(5):46. PubMed ID: 33760988
[TBL] [Abstract] [Full Text] [Related]
[Next]
